A View LCS vs Reveal LINQ Insertable Cardiac Monitor

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

A View LCS

by Coreline Soft Co.

Reveal LINQ Insertable Cardiac Monitor

by Medtronic

AI Verdict

Tool A, AVIEW LCS, is an AI-powered medical imaging platform for comprehensive thoracic CT analysis, focusing on lung cancer screening, emphysema, and coronary artery calcification from CT scans. Tool B, Reveal LINQ, is an implantable cardiac monitor that uses AI to provide long-term, accurate heart monitoring for conditions like atrial fibrillation and syncope. While both tools utilize AI in cardiology, their primary functions and data sources differ significantly: Tool A analyzes CT images for structural and calcification issues, while Tool B continuously monitors ECG for rhythm abnormalities.

Choose A View LCS if…

Choose AVIEW LCS if your institution requires a comprehensive AI-powered platform for thoracic CT analysis, particularly for lung cancer screening programs. It excels in automated lung nodule detection, classification, and 3D volume quantification, alongside emphysema and coronary artery calcification scoring from a single low-dose CT scan. This tool is ideal for streamlining radiology workflows and generating detailed, automated reports for various thoracic pathologies.

View A View LCS →

Choose Reveal LINQ Insertable Cardiac Monitor if…

Choose Reveal LINQ Insertable Cardiac Monitor if you need long-term, continuous cardiac monitoring for patients experiencing infrequent or unexplained symptoms like syncope, palpitations, or dizziness, or those at increased risk of cardiac arrhythmias. Its AI algorithms reduce false alerts, enhancing diagnostic yield for conditions such as atrial fibrillation and cryptogenic stroke, making it suitable for extended monitoring where short-term solutions may be insufficient.

View Reveal LINQ Insertable Cardiac Monitor →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	A View LCS	Reveal LINQ Insertable Cardiac Monitor
Pricing	Contact for quote	Contact vendor
Deployment	Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker)	Implantable device with data transmitted to a cloud-based platform (CareLink™ network) via patient smartphone app or home communicator.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Tie

Tool A, AVIEW LCS, focuses on streamlining the analysis of CT scans for clinicians, offering automated reports and integrations into existing PACS systems. Tool B, Reveal LINQ ICM, prioritizes patient usability with a mobile app for data transmission and an implantable device that requires minimal patient interaction. Both aim for ease of use within their respective contexts, making a direct comparison difficult without specific user feedback for each.

Clinical Value

Tie

Both tools offer significant clinical value in their specialized areas. AVIEW LCS provides comprehensive thoracic CT analysis, aiding in early detection and quantification of lung cancer, emphysema, and coronary artery calcification. Reveal LINQ ICM offers long-term, accurate cardiac monitoring with AI to reduce false alerts, improving diagnostic yield for cardiac conditions. The 'winner' depends on the specific clinical need (radiology/pulmonology vs. cardiology).

Pricing & Value

Tie

Both tools require direct contact for pricing, making a transparent comparison of cost-effectiveness impossible. Both are FDA-cleared and HIPAA compliant, suggesting a high standard of quality and regulatory adherence, which contributes to their value. Without specific pricing details or detailed cost-benefit analyses, it's not possible to definitively declare a winner in this dimension.

Enterprise Readiness

A View LCS

AVIEW LCS offers flexible deployment options including cloud, hybrid, and on-premise solutions, as well as virtualized environments, making it adaptable to various IT infrastructures within an enterprise. Reveal LINQ ICM, while robust for remote monitoring, relies on an implantable device and a specific cloud platform (CareLink network), which might present different integration challenges for a broader enterprise healthcare system beyond cardiology departments.

Innovation

Tie

AVIEW LCS demonstrates innovation through its comprehensive multi-disease analysis from a single CT scan and its CT kernel conversion AI technology. Reveal LINQ ICM showcases innovation with its AccuRhythm AI algorithms for reducing false alerts in cardiac monitoring and its long battery life for an implantable device. Both leverage AI in distinct and impactful ways within their respective domains.

Support & Docs

Tie

Neither the provided structured facts nor general web searches offer specific details about the level of customer support, training, or documentation available for either product. Both are established companies in the medical device and AI space, suggesting a baseline level of support, but without explicit information, a distinction cannot be made.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	A View LCS	Reveal LINQ Insertable Cardiac Monitor
Name	A View LCS	Reveal LINQ Insertable Cardiac Monitor
Company	Coreline Soft Co.	Medtronic
Description	AVIEW LCS by Coreline Soft is an FDA-cleared AI-powered medical imaging platform for comprehensive thoracic CT analysis, specializing in lung cancer screening, emphysema quantification, and coronary artery calcification detection from a single low-dose CT scan.	The Medtronic LINQ IIu2122 Insertable Cardiac Monitor (ICM) with AccuRhythmu2122 AI algorithms provides long-term, accurate heart monitoring by using deep learning AI to reduce false alerts and enhance diagnostic yield for conditions like atrial fibrillation and syncope.
Key Features	Automated lung nodule detection and classification, Nodule volume quantification and measurement (3D), Lung-RADS scoring and reporting, Emphysema analysis and quantification (LAA), Coronary Artery Calcium (CAC) scoring (Agatston, volume, mass), Segmentation of major coronary arteries, Automated comprehensive report generation (PDF, DICOM PDF, SR), CT kernel conversion AI technology	AccuRhythmu2122 AI algorithms for reduced false alerts (AF and Pause), 4.5-year battery longevity (nominal settings), Continuous, long-term subcutaneous ECG monitoring, Remote programming capabilities, Enhanced ECG experience for clinical adjudication, MyCareLink Heartu2122 mobile app for patient data transmission, MyCareLink Relayu2122 home communicator for data transmission, MRI compatible (at u2264 3T with no post-insertion waiting)
Categories	Cardiology AI, Oncology AI, Radiology & Imaging AI	Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties	Cardiology, Pulmonology, Radiology	Cardiology, Pediatrics

Videos

Demos, reviews, and walkthroughs featuring A View LCS and Reveal LINQ Insertable Cardiac Monitor.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools fit into existing clinical workflows for diagnosis and patient management?

AVIEW LCS is designed to integrate into radiology workflows, providing automated analysis of thoracic CT scans for lung nodules, emphysema, and coronary artery calcification, and generating comprehensive reports that align with Lung-RADS categories. Reveal LINQ ICM, an implantable device, continuously monitors heart rhythms for an extended period, with data transmitted to a cloud-based platform (CareLinku2122 network) via a patient's smartphone or home communicator, allowing for remote programming and enhanced ECG adjudication.

What is the depth of EHR integration for each tool, and how does it impact data accessibility and reporting?

AVIEW LCS supports standard DICOM connectivity and integrates with existing PACS and RIS environments, offering worklist integration and pre-populated reports in formats like DICOM SC, Encapsulated PDF, Key Images, DICOM GSPS, DICOM SEG, and DICOM SR. The Reveal LINQ ICM transmits data to the CareLinku2122 network, which clinicians can access, and the system generates event, summary, and full reports. The CareLink Mobile Application also provides access to CareLink Network data via a mobile device for convenience.

What are the accuracy and sensitivity of each tool in detecting relevant clinical conditions?

AVIEW LCS has demonstrated high detection sensitivity (u2265 83%) and precision (u2264 10% volumetric error for nodules > 6 mm) for pulmonary nodules, and has shown to reduce false positivity rates and increase sensitivity in lung nodule detection. The Reveal LINQ ICM with AccuRhythmu2122 AI algorithms is designed to significantly reduce false alerts from AF and pause while preserving sensitivity, and has shown superior accuracy in AF detection with a low false positive rate.

What is the learning curve for physicians and support staff to effectively use each tool?

AVIEW LCS aims to optimize reading time and reduce workload through AI-based automatic analysis and comprehensive report generation, suggesting a streamlined process for radiologists. The Reveal LINQ ICM insertion procedure is minimally invasive and simplified, and the associated mobile manager app offers guided workflow animations and integrated patient education to streamline device programming and interrogation.

What kind of customer support and resources are available for each tool?

Coreline Soft provides dedicated onboarding support for AVIEW LCS, including technical integration, workflow configuration, and user training, and offers local technical and clinical support through trusted partners. Medtronic offers 24/7 technical support and patient services for the Reveal LINQ ICM, with specialists available by phone, and provides online self-help resources and patient manuals.

How do these tools facilitate multi-site rollouts and ensure consistency across different clinical locations?

AVIEW LCS is designed to support multi-site operations by applying the same detection algorithms and measurement protocols across all sites, which helps eliminate variability due to differences in reader experience or workstation configurations, ensuring standardized quality. It also supports the mandatory dual-reading workflow in programs like Germany's, ensuring consistency even when primary and secondary readers are at different institutions. For the Reveal LINQ ICM, data is transmitted to the centralized CareLinku2122 network, which can be accessed by clinicians, suggesting a consistent data management approach across multiple sites.